Posted by Michael Wonder on 09 Apr 2022
ATAGI statement on use of booster doses in adolescents aged 12-15 years
8 April 2022 - A statement from the ATAGI on booster doses in adolescents aged 12-15 years.
ATAGI notes on 8 April 2022, the TGA approved a booster dose of Comirnaty (Pfizer) COVID-19 vaccine for use in adolescents aged 12-15 years.
At this time, ATAGI does not recommend that adolescents aged 12-15 years need to receive a booster dose of Pfizer COVID-19 vaccine and will continue to review international evidence on efficacy of a booster in this age group.
